Synthetic ligands that activate the nuclear receptor, the farnesoid X receptor (FXR), improve insulin resistance, regulate glucose and lipid metabolism, and have direct anti-inflammatory and anti-fibrotic effects in animal NASH models [97,130]. Here, NR1H4 is linked to metabolic dysfunction-associated steatohepatitis.